Skip to main content
SpringerLink
Log in

Hypertensive Disorders of Pregnancy

  • Chapter
  • First Online:
Disorders of Blood Pressure Regulation

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

  • 2002 Accesses

Abstract

The hypertensive disorders of pregnancy (HDP) complicate approximately 10% of pregnancies worldwide and represent a major health issue, contributing to significant maternal-perinatal morbidity and mortality not only in developing countries but also in the Western world, where improved medical care is counterbalanced by an increased incidence.

In this chapter, after a brief introduction describing the physiological changes of pregnancy, we discuss the most recent classifications of HDP, highlighting their discordances as well as similarities, with special emphasis on blood pressure and proteinuria measurement. A section is devoted to chronic hypertension in pregnancy and its management. The core of this chapter is dedicated to preeclampsia with subsections covering epidemiology and risk factors, pathogenesis, predictors/biomarkers, clinical features and complications, medical and obstetrical management, and prevention. Finally, possible later-life sequelae are briefly discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Poppas A, Shroff SG, Korcarz CE et al (1997) Serial assessment of the cardiovascular system in normal pregnancy: role of arterial compliance and pulsatile arterial load. Circulation 95:2407–2415

    Article  CAS  PubMed  Google Scholar 

  2. Chapman AB, Abraham WT, Zamudio S et al (1998) Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 54:2056–2063

    Article  CAS  PubMed  Google Scholar 

  3. Sanghavi M, Rutherford JB (2014) Cardiovascular physiology of pregnancy. Circulation 130:1003–1008

    Article  PubMed  Google Scholar 

  4. Maynard SE, Karumanchi SA, Thadhani R (2015) Hypertension and kidney disease in pregnancy. In: Skorecki K, Chertow GM, Marsden PA, Maarten WT, ASL Y (eds) Brenner and Rector’s the kidney, 10th edn. Elsevier, London, pp 1792–1824

    Google Scholar 

  5. Odutayo A, Hladunevitch M (2012) Obsteric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy. Clin J Am Soc Nephrol 7:2073–2080

    Article  PubMed  Google Scholar 

  6. Clapp JF 3rd, Capeless E (1997) Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 80:1469–1473

    Article  PubMed  Google Scholar 

  7. Mahendru AA, Everett TR, Wilkinson IB et al (2014) A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. J Hypertens 32:849–856

    Article  CAS  PubMed  Google Scholar 

  8. Greenwood JP, Scott EM, Stoker JB et al (2001) Sympathetic neural mechanisms in normal and hypertensive pregnancy in humans. Circulation 104:2200–2220

    Article  CAS  PubMed  Google Scholar 

  9. Elsheikh A, Creatsas G, Mastorakos G et al (2001) The renin-aldosterone system during normal and hypertensive pregnancy. Arch Gynecol Obstet 264:182–185

    Article  CAS  PubMed  Google Scholar 

  10. Khraibi AA (2002) Renal interstitial hydrostatic pressure and sodium excretion in hypertension and pregnancy. J Hypertens Suppl 20:S21–S27

    Article  CAS  PubMed  Google Scholar 

  11. Davison JM (1997) Edema in pregnancy. Kidney Int Suppl 59:S90–S96

    CAS  PubMed  Google Scholar 

  12. Gant NF, Chand S, Whalley PJ et al (1974) The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol 43:854

    CAS  PubMed  Google Scholar 

  13. McGuane JT, Debrah JE, Debrah DO et al (2009) Role of relaxin in maternal systemic and renal vascular adaptations during gestation. Ann N Y Acad Sci 1160:304–312

    Article  CAS  PubMed  Google Scholar 

  14. Sherwood OD (2005) An “old hand’s” perspective of Relaxin 2004’s place along the relaxin trail. Ann N Y Acad Sci 1041:29–35

    Google Scholar 

  15. Ervasti M, Kotisaari S, Heinonen S, Punnonen K (2008) Elevated serum erythropoietin concentration is associated with coordinated changes in red blood cell and reticulocyte indices of pregnant women at term. Scand J Clin Lab Invest 68:160–165

    Article  CAS  PubMed  Google Scholar 

  16. Castro LC, Hobel CJ, Gornbein J (1994) Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta-analysis. Am J Obstet Gynecol 171:1642–1651

    Article  CAS  PubMed  Google Scholar 

  17. Robson SC, Hunter S, Moore M, Dunlop W (1987) Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol 94:1028–1039

    Article  CAS  PubMed  Google Scholar 

  18. Brunton PJ, Arunachalam S, Russel JA (2008) Control of neurohypophysial hormone secretion, blood osmolality and volume in pregnancy. J Physiol Pharmacol 59(suppl 8):27–45

    PubMed  Google Scholar 

  19. Oelkers W (2002) Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone. Eur J Contracept Reprod Health Care 7(suppl 3):19–26

    CAS  PubMed  Google Scholar 

  20. Lumbers ER, Pringle KG (2014) Roles of the circulating renin-angiotensin aldosterone system in human pregnancy. Am J Physiol Regul Integr Comp Physiol 306:R91–R101

    Article  CAS  PubMed  Google Scholar 

  21. Baker PN, Broughton Pipkin F, Symonds EM (1990) Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy. Clin Sci (Lond) 79:403–408

    Article  CAS  Google Scholar 

  22. Dunlop W (1981) Serial changes in renal haemodynamics during normal human pregnancy. Br J Obstet Gynaecol 88:1–9

    Article  CAS  PubMed  Google Scholar 

  23. Bader RA, Bader ME, Rose DF, Braunwald E (1955) Hemodynamics at rest and during exercise in normal pregnancy as studies by cardiac catheterization. J Clin Invest 34:1524–1536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Robson SC, Hunter S, Boys RJ, Dunlop W (1989) Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Phys 256(pt 2):H1060–H1065

    CAS  Google Scholar 

  25. Hunter S, Robson SC (1992) Adaptation of the maternal heart in pregnancy. Br Heart J 68:540–543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Canada H (2004) Special report on maternal mortality and severe morbidity in Canada – enhanced surveillance: the path to prevention. Minister of Public Works and Government Services Canada, Ottawa

    Google Scholar 

  27. Centre for Maternal and Child Enquiries (CMACE) (2011) Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–08. The eighth report on confidential enquiries into maternal deaths in the United Kingdom. BJOG 118(Suppl 1):1–203

    Google Scholar 

  28. Tranquilli AL, Dekker G, Magee L et al (2014) The classification diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens 4:97–104

    Article  CAS  PubMed  Google Scholar 

  29. American College of Obstetricians and Gynecologists: Task Force on Hypertension in Pregnancy (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 122:1122–1131

    Article  Google Scholar 

  30. Von Dadelszen P, Magee LA, Roberts JM (2013) Subclassification of pre-eclampsia. Hypertens Pregnancy 22:143–148

    Article  Google Scholar 

  31. Sibai BM (2011) Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol 205:191–198

    Article  PubMed  Google Scholar 

  32. Chancellor J, Thorp JM Jr (2008) Blood pressure measurement in pregnancy. BJOG 115:1076–1077

    Article  CAS  PubMed  Google Scholar 

  33. Pickering TG, Hall JE, Appel LJ et al (2005) Recommendations for blood pressure measurement in humans and experimental animals: a statement for professionals from the Subcommittee of Professional and Public education of the American Heart Association Council on high blood pressure research. Hypertension 45:142–161

    Article  CAS  PubMed  Google Scholar 

  34. Cote AM, Firoz T, Mattman A et al (2008) The 24-hour urine collection: gold standard or historical practice? Am J Obstet Gynecol 199:625–626

    Article  PubMed  Google Scholar 

  35. Magee LE, Pels A, Helewa MD et al (2015) The hypertensive disorders of pregnancy (29.3). Best Pract Research Clin Oobstet Gynecol 29:643–657

    Article  Google Scholar 

  36. Poon LC, Kametas N, Strobl I et al (2008) Inter-arm blood pressure differences in pregnant women. BJOG 115:1122–1130

    Article  CAS  PubMed  Google Scholar 

  37. Shennan A, Gupta M, Halligan A et al (1996) Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry. Lancet 347:139–142

    Article  CAS  PubMed  Google Scholar 

  38. Reinders LW, Mos CN, Thornton C et al (2006) Time poor: rushing decreases the accuracy and reliability of blood pressure measurement technique in pregnancy. Hypertens Pregnancy 25:81–91

    Article  PubMed  Google Scholar 

  39. Lowe SA, Bowyer, Lust K et al (2014) The SOMANZ guideline for the management of hypertensive disorders of pregnancy. http://www.somanz.org/

  40. Lo C, Taylor RS, Gamble G et al (2002) Use of automated home blood pressure monitoring in pregnancy: is it safe? [see comment]. Am J Obstet Gynecol 187:1321–1328

    Article  PubMed  Google Scholar 

  41. Stergiou GS, Giovas PP, Gkinos CP, Tzamouranis DG (2008) Validation of the a&D UM-101 professional hybrid device for office blood pressure measurement according to the international protocol. Blood Press Monit 13:37–42

    Article  PubMed  Google Scholar 

  42. NCGCNational Clinical Guideline Center, BHS (2011) Clinical management of primary hypertension in adults. NICE Clinical Guideline 127, London

    Google Scholar 

  43. Head GA, McGrath BP, Mihailidou AS et al (2012) Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens 30:253–266

    Article  CAS  PubMed  Google Scholar 

  44. Bellomo G, Narducci PL, Rondoni F et al (1999) Prognostic value of 24-hour blood pressure in pregnancy. JAMA 282:1447–1452

    Article  CAS  PubMed  Google Scholar 

  45. Brown MA, Mangos G, Davis G, Homer C (2005) The natural history of white coat hypertension during pregnancy. BJOG 112:601–606

    Article  PubMed  Google Scholar 

  46. Brown MA, Davis GK, McHugh L (2012) The prevalence and clinical significance of nocturnal hypertension in pregnancy. J Hypertension 19(8):1437–1444

    Google Scholar 

  47. Magee LA, Ramsay G, von Dadelszen P (2008) What is the role of out-of-office BP measurement in hypertensive pregnancy? Hypertens Pregnancy 27:95–101

    Article  CAS  PubMed  Google Scholar 

  48. Magee LA, von Dadelszen P, Chan S et al (2007) The control of hypertension in pregnancy study pilot trial. BJOG 114:770.e13–770.e20

    Article  Google Scholar 

  49. Pickering TJ (1991) Ambulatory monitoring and blood pressure variability. Science Press Ltd, London, England

    Google Scholar 

  50. Brown MA, Roberts LM, Mackenzie C et al (2011) A prospective randomized study of automated versus mercury blood pressure recordings in hypertensive pregnancy (PRAM study). Hypertens Pregnancy 31:107–119

    Article  PubMed  Google Scholar 

  51. Brown MA, Robinson A, Bowyer L, Buddle ML et al (1998) Ambulatory blood pressure monitoring in pregnancy: what is normal? Am J Obstet Gynecol 178:836–842

    Article  CAS  PubMed  Google Scholar 

  52. Martin JN Jr, May WL, Magann EF et al (1999) Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 180:1407–1414

    Article  PubMed  Google Scholar 

  53. Lee-Ann Hawkins T, Brown MA, Mangos GJ, Davis GK (2012) Transient gestational hypertension: not always a benign event. Pregnancy Hypertens 2:22–27

    Article  CAS  PubMed  Google Scholar 

  54. Reinders A, Cuckson AC, Lee JT, Shennan AH (2005) An accurate automated blood pressure device for use in pregnancy and preeclampsia: the microlife 3BTO-A. BJOG 112:915–920

    Article  CAS  PubMed  Google Scholar 

  55. Villar J, Say L, Shennan A et al (2004) Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Int J Gynaecol Obstet 85(Suppl 1):S28–S41

    Article  CAS  PubMed  Google Scholar 

  56. Rey E, Morin F, Boudreault J et al (2009) Blood pressure assessments in different subtypes of hypertensive pregnant women: office versus home patient-or nurse measured blood pressure. Hypertens Pregnancy 28:168–177

    Article  PubMed  Google Scholar 

  57. Hermida RC, Ayala DE, Iglesias M (2003) Circadian rhythm of blood pressure challenges office values as the “gold standard” in the diagnosis of gestational hypertension. Chronobiol Int 20:135–156

    Article  PubMed  Google Scholar 

  58. Sibai BM (2002) Chronic hypertension in pregnancy. Obstet Gynecol 100:369–377

    Article  PubMed  Google Scholar 

  59. Vanek M, Sheiner E, Levy A, Mazor M (2004) Chronic hypertension and the risk for adverse pregnancy outcome after superimposed preeclampsia. Int J Gynecol Obstet 86:7–11

    Article  CAS  Google Scholar 

  60. Lawler J, Osman M, Shelton JA, Yeh J (2007) Population based analysis of hypertensive disorders of pregnancy. Hypertens Pregnancy 26:67–76

    Article  PubMed  Google Scholar 

  61. Hutcheon JA, Lisonkova S, Joseph KS (2011) Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 25:391–403

    Article  PubMed  Google Scholar 

  62. Roberts CL, Algert CS, Morris JM et al (2005) Hypertensive disorders in pregnancy: a population-based study. Med J Aust 182:332–335

    PubMed  Google Scholar 

  63. Ahmad AS, Samuelsen SO (2012) Hypertensive disorders in pregnancy and fetal death at different gestational lengths: a population study of 2 121 371 pregnancies. BJOG 119:1521–1528

    Article  CAS  PubMed  Google Scholar 

  64. Seely E, Ecker J (2011) Chronic hypertension in pregnancy. N Engl J Med 365:439–446

    Article  CAS  PubMed  Google Scholar 

  65. Rey E, Couturier A (1994) The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 171:410–416

    Article  CAS  PubMed  Google Scholar 

  66. McCowan LM, Buist RG, North RA, Gamble G (1996) Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 103:123–129

    Article  CAS  PubMed  Google Scholar 

  67. Chappell LC, Enye S, Seed P et al (2008) Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension. Hypertension 51:1002–1009

    Article  CAS  PubMed  Google Scholar 

  68. Catov JM, Nohr EA, Olsen J, Ness RB (2008) Chronic hypertension related to risk for preterm and term small for gestational age births. Obstet Gynecol 112:290–296

    Article  PubMed  PubMed Central  Google Scholar 

  69. Bateman BT, Huybrechts KF, Fischer MA et al (2015) Chrobic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol 212:e1–e14

    Article  Google Scholar 

  70. Xie RH, Guo Y, Krewski D et al (2013) Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population. Eur J Obstet Gynecol Reprod Biol 171:281–285

    Article  CAS  PubMed  Google Scholar 

  71. Caton AR, Bell EM, Druschel CM et al (2009) Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 54:63–70

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Yakoob MY, Bateman BT, Ho E et al (2013) The risk of congenital malformations associated with exposure to beta-blockers early in pregnancy: a meta-analysis. Hypertension 62:375–381

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Finer LB, Henshaw SK (2006) Disparities in unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 38:90–96

    Article  PubMed  Google Scholar 

  74. Magee LA, von Dadelszen P, Rey E et al (2015) Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 372:407–417

    Article  CAS  PubMed  Google Scholar 

  75. Publications Committee SMFM (2015) SMFM statement: benefit of antihypertensive therapy for mild to moderate hypertension during pregnancy remains uncertain. Am J Obstet Gynecol 213:3–4

    Article  Google Scholar 

  76. Tabacova S, Kimmel CA, Wall K, Hansen D (2003) Atenolol development toxicity: animal-to-human comparisons. Birth Defects Res A Clin Mol Teratol 67:181–192

    Article  CAS  PubMed  Google Scholar 

  77. Collins R, Yusuf S, Peto R (1985) Overview of randomised trials of diuretics in pregnancy. Br Med J (Clin Res Ed) 290:17–23

    Article  CAS  Google Scholar 

  78. Brent RL, Beckman DA (1991) Angiotensin converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors. Teratology 43:543–546

    Article  CAS  PubMed  Google Scholar 

  79. Gersak K, Cvijic M, Cerar LK (2009) Angiotensin II receptor blockers in pregnancy: a report of five cases. Reprod Toxicol 28:109–112

    Article  CAS  PubMed  Google Scholar 

  80. Serreau R, Luton D, Macher MA et al (2005) Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases. BJOG 112:710–712

    Article  CAS  PubMed  Google Scholar 

  81. Pergament E, Schechtman AS, Roth K (1996) Calcium channel blockers and pregnancy. fetal-exposure.org 5(1)

    Google Scholar 

  82. Duley LMS, Jones L (2013) Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 7:CD001449. doi:10.1002/14651858.CD001449.pub3

    Google Scholar 

  83. Hutcheon JA, Lisonkova S, Joseph KS (2011) Epidemiology of preeclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynecol 25:391–403

    Article  Google Scholar 

  84. Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33:130–137

    Article  PubMed  Google Scholar 

  85. Fong A, Chau CT, Pan D, Ogunyemi DA (2013) Clinical morbidities trends and demographics of eclampsia: a population –based study. Am J Obstet Gynecol 209:e1–e7

    Article  Google Scholar 

  86. Abalos E, Cuesta C, Grosso AL, Chou D, Say L (2013) Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 170:1–7

    Article  PubMed  Google Scholar 

  87. van Oostwaard MF, Langenfeld J, Schuit E et al (2015) Recurrence of hypertensive disorders of pregnancy. Am J Obstet Gynecol 212:e1–e17

    Article  Google Scholar 

  88. Hlimi T (2015) Association of anemia, pre-eclampsia and eclampsia with seasonality: a realistic systematic review. Health Place 31:180–192

    Article  PubMed  Google Scholar 

  89. Melo B, Amorim M, Katz L et al (2014) Hypertension, pregnancy and weather: is seasonality involved? Rev Assoc Med Braz 60:105–110

    Article  Google Scholar 

  90. Hernandez-Diaz S, Toh S, Cnattingius S (2009) Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 338:b2255

    Article  PubMed  PubMed Central  Google Scholar 

  91. Mogren I, Hogberg U, Winkvist A, Stenlund H (1999) Familial occurrence of pre-eclampsia. Epidemiology 10:518–522

    Article  CAS  PubMed  Google Scholar 

  92. Robillard PY, Hulsey TC, Alexander GR et al (1993) Paternity patterns and risk of pre-eclampsia in the last pregnancy in multiparae. J Reprod Immunol 24:1–12

    Article  CAS  PubMed  Google Scholar 

  93. Dekker G, Robillard PY, Roberts C (2011) The etiology of preeclampsia: the role of the father. J Reprod Immunol 89:126–132

    Article  PubMed  Google Scholar 

  94. Hartikainen AL, Aliharmi RH, Rantakillo PT (1998) A cohort study of epidemiologic associations and outcomes of pregnancies with hypertensive disorders. Hypertens Pregnancy 17:31–41

    Article  Google Scholar 

  95. Ros HS, Cnattingius S, Lipworth L (1998) Comparison of risk factors for pre-eclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 147:1062–1070

    Article  CAS  PubMed  Google Scholar 

  96. Katsi V, Felekos I, Siristatidis C et al (2015) Preeclampsia: what does the father have to do with it? Curr Hypertens Rep 17:576–577

    Article  CAS  Google Scholar 

  97. Mathiesen ER, Ringholm L, Feldt-Rasmussen B et al (2012) Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment. Clin J Am Soc Nephrol 7:2081–2088

    Article  CAS  PubMed  Google Scholar 

  98. Mission JF, Marshall NE, Caughey AB (2015) Pregnancy risks associated with obesity. Obstet Gynecol Clin N Am 42:335–353

    Article  Google Scholar 

  99. Duckitt K, Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330:565

    Article  PubMed  PubMed Central  Google Scholar 

  100. Carr DB, Epplein M, Johnson CO et al (2005) A sister’s risk: family history as a predictor of preeclampsia. Am J Obstet Gynecol 193:965–972

    Article  PubMed  Google Scholar 

  101. Eskenazi B, Fenster L, Sidney S (1991) A multivariate analysis of risk factors for preeclampsia. JAMA 266:237–241

    Article  CAS  PubMed  Google Scholar 

  102. Mostello D, Catlin TK, Roman L et al (2002) Preeclampsia in the parous woman: who is at risk? Am J Obstet Gynecol 187:425–429

    Article  PubMed  Google Scholar 

  103. Zetterstrom K, Lindeberg SN, Haglund B et al (2005) Maternal complications in women with chronic hypertension: a population-based cohort study. Acta Obstet Gynecol Scand 84:419–424

    Article  PubMed  Google Scholar 

  104. Palmer SK, Moore LG, Young D et al (1999) Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol 180:1161–1168

    Article  CAS  PubMed  Google Scholar 

  105. Krotz S, Fajardo J, Ghandi S et al (2002) Hypertensive disease in twin pregnancies: a review. Twin Res 5:8–14

    Article  PubMed  Google Scholar 

  106. Ness RB, Markovic N, Bass D et al (2003) Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 102:1366–1371

    PubMed  Google Scholar 

  107. Clowse MEB, Jamison M, Myers E et al (2008) A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199(2):121–127

    Article  Google Scholar 

  108. Weiss JL, Malone FD, Emig D et al (2004) Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol 90:1091–1097

    Article  Google Scholar 

  109. DeVader SR, Neeley HL, Myles TD et al (2007) Evaluation of gestational weight gain guidelines for women with normal prepregnancy body mass index. Obstet Gynecol 110:745–751

    Article  PubMed  Google Scholar 

  110. Michikawa T, Morokuma S, Fukushima K et al (2015) A register-based study of the association between air pollutants and hypertensive disorders of pregnancy in the Japanese population. Environ Res 142:644–650

    Article  CAS  PubMed  Google Scholar 

  111. Strevens H, Wide-Svensson D, Hansen A et al (2003) Glomerular endotheliosis in normal pregnancy and preeclampsia. BJOG 110:831–836

    Article  CAS  PubMed  Google Scholar 

  112. Romero R, Dey SK, Fisher SJ (2014) Preterm labor: one syndrome, many causes. Science 345:760–765

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Fisher SJ (2015) Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol 213(suppl 4):s115–s122

    Article  PubMed  PubMed Central  Google Scholar 

  114. Shah D, Khalil RA (2015) Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol 95:211–226

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Levine RJ, Lam C, Qian C et al (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992–1005

    Article  CAS  PubMed  Google Scholar 

  116. Goulopoulou S, Davidge ST (2015) Molecular mechanisms of maternal vascular dysfunction in preeclampsia. Trends Mol Med 21:88–97

    Article  CAS  PubMed  Google Scholar 

  117. Young BC, Levine RJ, Karumanchi AS (2010) Pathogenesis of preeclampsia. Annu Rev Pathol Mech Dis 5:173–192

    Article  CAS  Google Scholar 

  118. Agarwal I, Karumanchi A (2011) Preeclampsia and the anti-angiogenic state. Pregnancy Hypertens 1:17–21

    Article  PubMed  PubMed Central  Google Scholar 

  119. Kendall RL, Thomas KA (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A 90:10705–10709

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. George EM, Palei AC, Granger JP et al (2012) Endothelin as a final common pathway in the pathophysiology of preeclampsia: therapeutic implications. Curr Opin Nephrol Hypertens 21:157–162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Naljayan MV, Karumanchi AS (2013) New developments in the pathogenesis of preeclampsia. Adv Chronic Kidney Dis 20:265–270

    Article  PubMed  PubMed Central  Google Scholar 

  122. Knock GA, Poston L (1996) Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 175:1668–1674

    Article  CAS  PubMed  Google Scholar 

  123. Kenny LC, Baker PN, Kendall DA et al (2002) Differential mechanisms of endothelium- dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin Sci (Lond) 103:67–73

    Article  CAS  Google Scholar 

  124. Bobst SM, Day MC, Gilstrap LC 3d et al (2005) Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 18: 330–336

    Google Scholar 

  125. Herse F, LaMarca B (2013) Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am J Reprod Immunol 69:413–418

    Article  CAS  PubMed  Google Scholar 

  126. Cotechini T, Graham CH (2015) Aberrant maternal inflammation as a cause of pregnancy complications: a potential therapeutic target? Placenta 36:960–966

    Article  CAS  PubMed  Google Scholar 

  127. Borzychowski AM, Sargent IL, Redman CW (2006) Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 11:309–316

    Article  CAS  PubMed  Google Scholar 

  128. Regal JF, Gilbert JS, Burwick RM (2015) The complement system and adverse pregnancy outcomes. Mol Immunol 67:56–70

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Burger D, Shock S, Thompson CS et al (2013) Microparticles: biomarkers and beyond. Clin Sci (Lond) 124:423–441

    Article  CAS  Google Scholar 

  130. Schoofs K, Grittner U, Engels T et al (2014) The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction. J Perinat Med 42:61–68

    Article  CAS  PubMed  Google Scholar 

  131. Zeisler H, Llurba E, Chantraine F et al (2016) Predictive value of the sFlt-1:PlGF in women with suspected preeclampsia. N Engl J Med 374:13–22

    Article  CAS  PubMed  Google Scholar 

  132. Bramham K, Seed PT, Lightstone L et al (2016) Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89:874–885

    Article  CAS  PubMed  Google Scholar 

  133. Bellomo G (2012) Serum uric acid and pre-eclampsia: an update. Exp Rev Cardiovasc Ther 10:701–705

    Article  CAS  Google Scholar 

  134. Bellomo G, Venanzi S, Saronio P et al (2011) Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension 58:704–708

    Article  CAS  PubMed  Google Scholar 

  135. Jardim LL, Rios DR, Perucci LO et al (2015) Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia? Clin Chim Acta 447:34–38

    Article  CAS  PubMed  Google Scholar 

  136. Garovic VD (2014) The role of the podocyte in preeclampsia. Clin J Am Soc Nephrol 9:1337–1340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Spencer K, Cowans NJ, Chefetz I et al (2007) First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of preeclampsia. Ultrasound Obstet Gynecol 29:128–134

    Article  CAS  PubMed  Google Scholar 

  138. Alpoim PN, Godoi LC, Freitas LG et al (2013) Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia. Nitric Oxide 1(33):81–88

    Article  CAS  Google Scholar 

  139. Pozharny Y, Lambertini L, Clunie G et al (2010) Epigenetics in women's health care. Mt Sinai J Med 77(2):225–235

    Article  PubMed  Google Scholar 

  140. Pineles BL, Romero R, Montenegro D et al (2007) Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196:261.e1–261.e6

    Article  CAS  Google Scholar 

  141. Pillar N, Yoffe L, Hod M, Shomron N (2015) The possible involvement of microRNAs in preeclampsia and gestational diabetes mellitus. Best Pract Res Clin Obstet Gynaecol 29:176–182

    Article  PubMed  Google Scholar 

  142. Uddin MN, Allen SR, Jones RO et al (2012) Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome. Transl Res 160:99–113

    Article  CAS  PubMed  Google Scholar 

  143. Williamson R, O’Keeffe GW, Kenny LC (2015) Activin signaling and preeclampsia: ff rom genetic risk to pre-symptomatic biomarker. Cytokine 71:360–365

    Article  CAS  PubMed  Google Scholar 

  144. Barati M, Shahbazian N, Ahmadi L et al (2014) Diagnostic evaluation of uterine artery Doppler sonography for the prediction of adverse pregnancy outcomes. J Res Med Sci 19:515–519

    PubMed  PubMed Central  Google Scholar 

  145. Kleinrouweler CE, Cheong-See FM, Collins GS et al (2016) Prognostic models in obstetrics: available, but far from applicable. Am J Obstet Gynecol 214:79–90

    Article  PubMed  Google Scholar 

  146. Sibai BM, Stella CL (2008) Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 200:481e1–481.e7

    Article  Google Scholar 

  147. Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181–192

    PubMed  Google Scholar 

  148. Douglas KA, Redman CW (1994) Eclampsia in the United Kingdom. BMJ 309:1395–1400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  149. Knight M, UKOSS (2007) Eclampsia in the United Kingdom 2005. BJOG 114:1072–1078

    Article  CAS  PubMed  Google Scholar 

  150. Martin JN Jr, Rose CH, Briery CM (2006) Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 195:914–934

    Article  CAS  PubMed  Google Scholar 

  151. Shainker SA, Edlow JA, O’Brien K (2015) Cerebrovascular emergency in pregnancy. Best Pract Res Clin Obstet Gynaecol 29:721–731

    Article  PubMed  Google Scholar 

  152. Singhal A (2004) Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 61:411–416

    Article  PubMed  Google Scholar 

  153. Singhal AB, Kimberly WT, Schaefer PW et al (2009) Case 8-2009: a 36-year-old woman with headache, hypertension, and seizure 2 weeks post partum. N Engl J Med 360:1126–1137

    Article  CAS  PubMed  Google Scholar 

  154. Singhal AB, Hajj-Ali RA, Topcuoglo MA et al (2011) Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 68:1005–1012

    Article  PubMed  Google Scholar 

  155. Fugate JE, Ameriso SF, Ortiz G et al (2012) Variable presentations of postpartum angiopathy. Stroke 43:670–676

    Article  PubMed  Google Scholar 

  156. Ursell MR, Marras CL, Farb R et al (1998) Recurrent intracranial hemorrhage due to postpartum cerebral angiopathy: implications for management. Stroke 29:1995–1998

    Article  CAS  PubMed  Google Scholar 

  157. Ducros A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11:906–917

    Article  PubMed  Google Scholar 

  158. Garcia-Reitboeck P, Al-Memar A (2013) Reversible cerebral vasoconstriction after preeclampsia. N Engl J Med 369:–364

    Google Scholar 

  159. Singhal, Aneesh B, Bernst in RA (2005) Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit Care 3:91–97

    Google Scholar 

  160. Fugate JE, Claassen DO, Cloft HJ et al (2014) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427–432

    Article  Google Scholar 

  161. Ducros A, Boukobza M, Sarov M et al (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130:3091–3101

    Article  PubMed  Google Scholar 

  162. Bateman BT, Schumacher HC, Bushnell CD et al (2006) Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology 67:424–429

    Article  CAS  PubMed  Google Scholar 

  163. James AH, Bushnell CD, Jamison MG et al (2005) Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 106:509–516

    Article  PubMed  Google Scholar 

  164. Fakhouri F, Vercel C, Frémeaux-Bacchi V (2012) Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol 7:2100–2106

    Article  PubMed  Google Scholar 

  165. Prakash J, Niwas SS, Parekh A et al (2010) Acute kidney injury in late pregnancy in developing countries. Ren Fail 32:309–313

    Article  PubMed  Google Scholar 

  166. Stratta P, Besso L, Canavese C et al (1996) Is pregnancy-related acute renal failure a disappearing clinical entity? Ren Fail 18:575–584

    Article  CAS  PubMed  Google Scholar 

  167. Arora N, Mahajan K, Jana N, Taraphder A (2010) Pregnancy-related acute renal failure in eastern India. Int J Gynaecol Obstet 111:213–216

    Article  PubMed  Google Scholar 

  168. Prakash J, Vohra R, Wani IA, Murthy AS et al (2007) Decreasing incidence of renal cortical necrosis in patients with acute renal failure in developing countries: a single-centre experience of 22 years from eastern India. Nephrol Dial Transplant 22:1213–1217

    Article  PubMed  Google Scholar 

  169. Prakash J, Tripathi K, Pandey LK et al (1995) Spectrum of renal cortical necrosis in acute renal failure in eastern India. Postgrad Med J 71:208–210

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  170. Grunfeld JP, Ganeval D, Bournerias F (1980) Acute renal failure in pregnancy. Kidney Int 18:179–191

    Article  CAS  PubMed  Google Scholar 

  171. Chugh KS, Singhal PC, Sharma BK et al (1976) Datta BN: acute renal failure of obstetric origin. Obstet Gynecol 48:642–646

    CAS  PubMed  Google Scholar 

  172. Too G, Hill JB (2013) Hypertensive crisis during pregnancy and postpartum period. Semin Perinatol 37:280–287

    Article  PubMed  Google Scholar 

  173. Dennis AT, Chambers E, Serang K (2015) Blood pressure assessment and first-line pharmacological agents in women with eclampsia. Int J Obstet Anesth 24:247–251

    Article  CAS  PubMed  Google Scholar 

  174. Wacker JR, Wagner BK, Briese V et al (2006) Antihypertensive therapy in patients with preeclampsia: a prospective randomized multicentre study comparing dihydralazine with urapidil. Eur J Obstet Gynecol Reprod Biol 127:160–165

    Article  CAS  PubMed  Google Scholar 

  175. Magee LA, Yong PJ, Espinosa V et al (2009) Expectant management of severe preeclampsia remote from term: a structured systematic review. Hypertens Pregnancy 28:312–347

    Article  CAS  PubMed  Google Scholar 

  176. Koopmans CM, Bijlenga D, Groen H et al (2009) Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 374:979–988

    Article  PubMed  Google Scholar 

  177. Rosenstein MG, Snowden JM, Cheng YW, Caughey AB (2014) The mortality risk of expectant management compared with delivery stratified by gestational age and race and ethnicity. Am J Obstet Gynecol 211:e1–e8

    Article  Google Scholar 

  178. Thadhani R, Hagmann H, Schaarschmidt W et al (2016) Removal of soluble Fms-like tyrosin kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol 27:903–913

    Article  CAS  PubMed  Google Scholar 

  179. Bujold E, Roberge S, Nicolaides KH (2014) Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation. Prenat Diagn 34:642–648

    CAS  PubMed  Google Scholar 

  180. Duley L, Henderson-Smart DJ, Meher S et al (2007) Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2:CD004659

    Google Scholar 

  181. Kozer E, Nikfar S, Costei A et al (2002) Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 187:1623–1630

    Article  PubMed  Google Scholar 

  182. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA (2007) Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data. Lancet 369:1791–1798

    Article  CAS  PubMed  Google Scholar 

  183. Hofmeyr GJ, Lawrie TA, Atallah AN et al (2014) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 6:CD001059

    Google Scholar 

  184. Perez Lopez F, Pasupuleti V, Mezones Holguin E et al (2015) Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controller trials. Fertil Steril 103:1278–1288

    Article  CAS  PubMed  Google Scholar 

  185. Edison RJ, Muenke M (2004) Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet 131:287–298

    Article  PubMed  Google Scholar 

  186. Cleary KL, Roney K, Costantine M (2014) Challenges of studying drugs in pregnancy for off-label indications: pravastatin for preeclampsia prevention. Semin Perinatol 38:523–527

    Article  PubMed  Google Scholar 

  187. Costantine MM, Cleary K, Hebert MF et al (2016) Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high risk pregnant women: a pilot randomized controlled trial. Am J Obstet Gynecol 214:720.e1–720.e17

    Google Scholar 

  188. Seely EW, Tsigas E, Rich-Edwards JW (2015) Preeclampsia and future cardiovascular disease in women: how good are the data and how can we manage our patients? Semin Perinatol 39:276–283

    Article  PubMed  Google Scholar 

  189. Bellamy L, Casas JP, Hingorani AD, Williams DJ (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Br Med J 335:974–979

    Article  Google Scholar 

  190. Brown MC, Best KE, Pearce MS et al (2013) Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol 28:1–19

    Article  PubMed  Google Scholar 

  191. Sandvik MK, Leigul E, Nygard O et al (2013) Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol 209:e1–e101

    Article  Google Scholar 

  192. Habli M, Eftekhari N, Wiebracht E et al (2009) Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obstet Gynecol 201:385e1–385e5

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, MVT Hospital, Str.Buda 1, 06059, Todi(Pg), Italy

    Gianni Bellomo

Authors
  1. Gianni Bellomo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gianni Bellomo .

Editor information

Editors and Affiliations

  1. Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

    Adel E. Berbari

  2. Emeritus Professor of Medicine, University of Milano-Bicocca, Monza, Italy

    Giuseppe Mancia

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bellomo, G. (2018). Hypertensive Disorders of Pregnancy. In: Berbari, A., Mancia, G. (eds) Disorders of Blood Pressure Regulation. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-59918-2_44

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59918-2_44

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59917-5

  • Online ISBN: 978-3-319-59918-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation